HomeATTBF • OTCMKTS
add
Abattis Bioceuticals Ord Shs
Nakaraang pagsara
$0.00
Average na Volume
46.67K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(CAD) | 2019info | Y/Y na pagbabago |
---|---|---|
Kita | 356.88K | 4,163.24% |
Gastos sa pagpapatakbo | 4.15M | -73.70% |
Net na kita | -3.04M | 96.10% |
Net profit margin | -852.40 | 99.91% |
Kita sa bawat share | — | — |
EBITDA | -3.84M | 75.62% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(CAD) | 2019info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 2.40M | -73.59% |
Kabuuang asset | 19.26M | 68.97% |
Kabuuang sagutin | 8.59M | 2,734.79% |
Kabuuang equity | 10.67M | — |
Natitirang share | 476.05M | — |
Presyo para makapag-book | 0.00 | — |
Return on assets | -15.94% | — |
Return on capital | -22.30% | — |
Cash Flow
Net change in cash
(CAD) | 2019info | Y/Y na pagbabago |
---|---|---|
Net na kita | -3.04M | 96.10% |
Cash mula sa mga operasyon | 9.41M | 213.68% |
Cash mula sa pag-invest | -11.52M | 29.06% |
Cash mula sa financing | 60.00K | -99.79% |
Net change in cash | -2.04M | -157.79% |
Malayang cash flow | -2.46M | 65.86% |
Tungkol
Itinatag
1997
Headquarters
Website